Chitosan and its derivatives as drug penetration enhancers

Journal of Drug Delivery Science and Technology

Volumn 20, Issue 1, 2010, Pages 5-13

  Caramella, C ^a   Ferrari, F ^a   Bonferoni, M C ^a   Rossi, S ^a   Sandri, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Chitosan; Chitosan derivatives; Mucoadhesion; Nanoparticles; Penetration enhancement

Indexed keywords

ACICLOVIR; ASCORBIC ACID; CHITOSAN; CHITOSAN ASCORBATE; CHITOSAN CITRATE; CHITOSAN DERIVATIVE; EMULSIFYING AGENT; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INSULIN; KETONE DERIVATIVE; METHYLPYRROLIDINONE; NANOCAPSULE; NANOPARTICLE; PENETRATION ENHANCING AGENT; PROTEIN ZO1; TETRAMETHYLPYRAZINE; TRIMETHYLCHITOSAN; UNCLASSIFIED DRUG;

ACETYLATION; CHEEK MUCOSA; DRUG ABSORPTION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG METABOLISM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; MUCOADHESION; NONHUMAN; PH; REVIEW; SALIVA; STRUCTURE ACTIVITY RELATION; VAGINA EPITHELIUM; VAGINA FLORA;

EID: 76749091998     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(10)50001-7     Document Type: Review

References (74)

1. Artursson P., Lindmark T., Davis S.S., Illum L. - Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). - Pharm. Res., 11, 1358-1361, 1994.
2. Illum L., Farraj N.F., Davis S.S. - Chitosan as a novel nasal delivery system for peptide drugs. - Pharm. Res., 11, 1186-1189, 1994.
3. Schipper N.G.M., Olsson S., Hoogstraate J.A., Deboer A.G., Varum K.M., Artursson P. - Chitosan as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. - Pharm. Res., 14, 923-929, 1997.
4. Muzzarelli R., Muzzarelli C. - Chitosan in Pharmacy and Chemistry. - Ancona University, 2001.
5. Illum L. - Chitosan and its use as a pharmaceutical excipients - Pharm. Res., 15, 1326-1331, 1998.
6. Veuillez F., Kalia Y.N., Jacques Y., Deshusses J., Buri P. - Factors and strategies for improving buccal absorption of peptides. - Eur. J. Pharm. Biopharm., 51, 93-109, 2001.
7. Makhlof A., Werle M., Takeuchi H. - Mucoadhesive drug carriers and polymers for effective drug delivery. - J. Drug Deliv. Sci. Technol., 18, 375-386, 2008.
8. Jain S.K., Jain A., Gupta Y., Gupta A. - Progesterone bearing mucoadhesive carriers for nasal delivery. - J. Drug Deliv. Sci. Technol., 17, 137-143, 2007.
9. Genta I., Colonna C., Perugini P., Pavanetto F., Modena T., Valli M., Muzzarelli C., Conti B. - Evaluation of bioadhesive performance of chitosan derivatives as films for buccal application. - J. Drug Deliv. Sci. Technol., 15, 459-463, 2005.
10. Di Colo G., Zambito Y., Zaino C. - Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. - J. Pharm. Sci., 97, 1652-1680, 2008.
11. Schipper N.G.M., Varum K.M., Artursson P. - Chitosans as absorption enhancers for poorly absorbable drugs. 1 : influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. - Pharm. Res., 13, 1686-1692, 1996.
12. Thanou M., Verhoef J.C., Junginger H.E. - Oral drug absorption enhancement by chitosan and its derivatives. - Adv. Drug Deliv. Rev., 52, 117-126, 2001.
13. Dodane V., Khan M.A., Merwin J.R. - Effect of chitosan on epithelial permeability and structure. - Int. J. Pharm., 182, 21-23, 1999.
14. Smith J., Wood E., Dornish M. - Effect of chitosan on epithelial cell tight junctions. - Pharm. Res., 21, 43-49, 2004.
15. Chan V., Mao H.-Q., Leong K.M. - Chitosan-induced perturbation of dipalmitoyl-sn-glycero-3-phosphocholine membrane bilayer. - Langmuir, 17, 3749-3756, 2001.
16. Luessen H.I., De Leeuw B.J., Langemeijer M.W.E., Deboer A.G., Verhoerf J., Junginger H.E. - Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. - Pharm. Res., 13, 1668-1672, 1996.
17. Schipper N.G.M., Varum K.M., Stenberg P., Ocklind G., Lennernas H., Artursson P. - Chitosans as absorption enhancers of poorly absorbable drugs 3: influence of mucus on absorption enhancement. - Eur. J. Pharm. Sci., 8, 335-343, 1999.
18. Kotzè A.F., Luessen H.L., De Leeux B.J., De Boer A.G., Verhoef J.C., Junginger H.E. - N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2). - Pharm. Res., 14, 1197-1202, 1997.
19. Kotzè A.F., Luessen H.L., De Leeux B.J., De Boer A.G., Verhoef J.C., Junginger H.E. - Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). - J. Control. Release, 51, 35-46, 1998.
20. Thanou M.M., Verhoef J.C., Romeijn S.G., Nagelkerke J.F., Merkus F.W.H.M., Junginger H.E. - Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on Caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea. - Int. J. Pharm., 185, 73-82, 1999.
21. Thanou M., Kotzè A.F., Scharringhausen T., Luessen H.L., De Boer A.G., Verhoef J.C., Junginger H.E. - Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across Caco-2 cell monolayers. - J. Control. Release, 64, 15-25, 2000.
22. Thanou M., Verhoef J.C., Marbach P., Junginger H.E. - Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of somatostatin analogue in vitro and in vivo. - J. Pharm. Sci., 89, 951-957, 2000.
23. Thanou M., Florea B.I., Langermeyer M.W.E., Verhoef J. C, Junginger H.E. - N-Trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug Buserelin in vitro (Caco-2 cells) and in vivo (rats). - Pharm. Res., 17, 27-31, 2000.
24. Van Der Merwe S.M., Verhoef J.C., Kotzè A.F., Junginger H.E. - N-Trimethyl chitosan chloride (TMC) as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablets and granule formulations. - Eur. J. Pharm. Biopharm., 57, 85-91, 2004.
25. Sahni J.K., Chopra S., Ahmad F.J., Khar R.K. - Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications. - J. Pharm. Pharmacol., 60, 1111-1119, 2008.
26. Mourya V.K., Inamdar N.N. -Trimethyl chitosan and its application in drug delivery. - J. Mater. Sci. Mater. Med., 20, 1057-1079, 2009.
27. Avadi M.R., Erfan M., Sadeghi A.M.M., Moezi L., Dehpour A.R., Younessi P., Rafiee Tehrani M., Shafiee A. - N,N-diethyl N-methyl chitosan as an enhancing agent for colon drug delivery. - J. Bioact. Compat. Polym., 19, 421-433, 2004.
28. Younessi P., Avadi M.R., Shamimi K., Sadeghi A.M.M., Moezi L., Nahid E., Bayati K., Dehpour A.R., Rafiee-Tehrani M. - Preparation and ex vivo evaluation of TEC as an absorption enhancer for poorly absorbable compounds in colon specific drug delivery. - Acta Pharm., 54, 339-345, 2004.
29. Korjamo T., Holappa J., Taimisto S., Savolaimen J., Jarvinen T., Monkkonen J. - Effect of N-betainate and N-piperazine derivatives of chitosan on the paracellular transport of mannitol in Caco-2 cells. - Eur. J. Pharm. Sci., 35, 226-234, 2008.
30. +-Ch) for enhanced intestinal drug permeation. - Eur. J. Pharm. Sci., 33, 343-350, 2008.
31. Bernkop-Schnurch A.,Kast C.E., Guggi D. - Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. - J. Control. Release, 93, 95-103, 2003.
32. Bernkop-Schnurch A., Guggi D., Pinter Y. - Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. - J. Control. Release, 94, 177-186, 2004.
33. Bernkop-Schnurch A., Krauland A.H., Leitner V.M., Palmberger T. - Thiomers: potential excipients for non-invasive peptide delivery systems. - Eur. J. Pharm. Biopharm., 58, 253- 263, 2004.
34. Werle M., Bernkop-Schnurch A. - Thiolated chitosans: useful excipients for oral drug delivery. - J. Pharm. Pharmacol., 60, 273-281, 2008.
35. Palmberger T.F., Hombach J., Bernkop-Schnurch A. - Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir. - Int. J. Pharm., 348, 54-60, 2008.
36. Werle M., Hoffer M. - Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. - J. Control. Release, 111, 41-46, 2006.
37. Tengamnuay P., Sahamethapat A., Sailasuta A., Mitra A.K. - Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. - Int. J. Pharm., 197, 53-67, 2000.
38. Zaki N.M., Mortada N.D., Awad G.A.S., Abd Elhady S.S. - Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation. - Int. J. Pharm., 327, 97-103, 2006.
39. Hamman J.H., Stander M., Kotzè A.F. - Effect of the degree of quaternization of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia. - Int. J. Pharm., 232, 235-242, 2002.
40. Mei D., Mao S., Sun W., Wang Y., Kissel T. - Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats. - Eur. J. Pharm. Biopharm., 70, 874-881, 2008.
41. Wu J., Wei W., Wang L.-Y, Su Z.-G., Ma G.-H. - A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system. - Biomaterials, 28, 2220-2232, 2007.
42. Salamat-Miller N., Chittchang M., Johnston T.P. - The use of mucoadhesive polymers in buccal drug delivery. - Adv. Drug Deliv. Rev., 57, 1666-1691, 2005.
43. Smart J. D. - Drug delivery using buccal-adhesive systems. - Adv. Drug Del. Rev., 11, 253-270, 1993.
44. Senel S., Kremer M.J., Kas S., Wertz P.W., Hincal A. A., Squier C.A. - Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. - Biomaterials, 21, 2067-2071, 2000.
45. Senel S., Hincal A.A. - Drug permeation enhancement via buccal route: possibilities and limitations. - J. Control. Release, 72, 133-144, 2001.
46. Sandri G., Poggi P., Bonferoni M.C, Rossi S., Ferrari F., Caramella C. - Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan.-J. Pharm. Pharmacol., 58, 1327-1336, 2006.
47. Sandri G., Rossi S., Perrari F., Bonferoni M.C., Muzzarelli C., Caramella C. - Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. - Eur. J. Pharm. Sci., 21, 351-359, 2004.
48. Rossi S., Sandri G., Ferrari F., Bonferoni M.C, Caramella C. - Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid. - Pharm. Dev. Technol., 8, 199-208, 2003.
49. Sandri G., Rossi S., Bonferoni M.C, Perrari F., Zambito Y., Di Colo G., Caramella C. - Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule. - Int. J. Pharm., 297, 146-155, 2005.
50. Rossi S, Marciello M, Sandri G, Bonferoni M.C, Perrari F., Caramella C. - Chitosan ascorbate: a chitosan new salt with improved penetration enhancement properties. - Pharm. Dev. Technol., 13, 513-521, 2008.
51. Muzzarelli R.A.A. - Chitosan-based dietary foods. - Carbohydr. Polym., 29, 309-316, 1996.
52. Tsujikawa T, Kanauchi O., Andoh A., Saotome T., Sasaki M., Fujiyama Y., Bamba T. - Supplement of a chitosan and ascorbic acid mixture for Crohn's disease: a pilot study. - Nutrition, 19, 137-139, 2003.
53. Kanauchi O., Deuchi K., Imasato Y., Kobayashi E. - Increasing effect of a chitosan and ascorbic acid mixture on fecal dietary fat excretion. - Biosci. Biotechnol. Biochem., 58, 1617-1620, 1994.
54. Hussain A., Ahsan F. - The vagina as a route for systemic drug delivery. - J. Control. Release, 103, 301-313, 2005.
55. Sandri G., Rossi S., Ferrari F., Bonferoni M.C., Caramella C. - Strategies to improve systemic and local availability of drugs administered via vaginal route - In: Enhancement in Drug Delivery, Chap. 7, E. Touitou and B.W. Barry Eds., Taylor and Francis, CRC Press, Boca Raton, 2007, pp. 441-470.
56. Valenta C. - The use of mucoadhesive polymers in vaginal delivery. - Adv. Drug Deliv. Rev., 57, 1692-1712, 2005.
57. Rossi S., Sandri G., Ferrari F., Bonferoni M.C, Caramella C. - Development of films and matrices based on chitosan and polyacrylic acid for vaginal delivery of acyclovir. - STP Pharma Sci., 13, 183-190, 2003.
58. Bonferoni M.C., Sandri G., Rossi S., Ferrari F., Gibin S., Caramella C. - Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties. - Eur. J. Pharm Sci., 33, 166-176, 2008.
59. Valenta C., Marschütz M., Egyed C., Bernkop-Schnürch A. - Evaluation of the inhibition effect of thiolated poly(acrylates) on vaginal membrane bound aminopeptidase N and release of the model drug LH-RH. - J. Pharm. Pharmacol., 54, 603-610, 2002.
60. Lee V.H.L. - Enzymatic barriers to peptide and protein absorption. - Crit. Rev.Ther. Drug. Carrier Syst., 5, 69-97, 1988.
61. Behrens I., Vila Pena A.I., Alonso M.J., Kissel T. - Comparative uptake studies of bioadhesive and non bioadhesive nanoparticles to human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. - Pharm. Res., 19, 1185-1193, 2002.
62. Takeuchi H., Yamamoto H., Kawashima Y. - Mucoadhesive nanoparticulate systems for peptide drug delivery. - Adv. Drug Del. Rev., 47, 39-54, 2001.
63. Ponchel G., Montisci M.-J., Dembri A., Durrer C., Duchêne D. - Mucoadhesion of colloidal particulate systems in the gastrointestinal tract - Eur. J. Pharm. Biopharm., 44, 25-31, 1997.
64. Ma Z., Lim L.-Y - Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and nanoparticles. - Pharm. Res., 20, 1812-1819, 2003.
65. Pan Y., Li Y., Zhao H., Zheng J., Xu H., Wei G., Hao J., Cui R - Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. - Int. J. Pharm., 249, 139-147, 2002.
66. Sarmento B., Ribeiro A., Veiga F., Sampaio P., Neufeld R., Ferriera D. - Alginate/chitosan nanoparticles are effective for oral insulin delivery. - Pharm. Res., 24, 2198-2206, 2007.
67. Sarmento B., Ribeiro A., Veiga F., Ferreira D., Neufeld R. - Oral bioavailability of insulin contained in polysaccharide nanoparticles. - Biomacromolecules, 8, 3054-3060, 2007.
68. Sonaje K., Lin Y.-H., Juang J.-H., Wey S.-P., Chen C.-T., Sung H.-W. - In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. - Biomaterials, 30, 2329-2339, 2009.
69. Prego C., Fabre M., Torres D., Alonso M.J. - Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. - Pharm. Res., 23, 549-556, 2006.
70. Prego C., Torres D., Alonso M.J. - Chitosan nanocapsules: a new carrier for nasal peptide delivery. - J. Drug Deliv. Sci. Technol., 16, 331-337, 2006.
71. Fernandez-Urrusuno R., Calvo P., Remunan-Lopez C, Vila-Jato J.L., Alonso M.J. - Enhnacement of nasal absorption of insulin using chitosan nanoparticles. - Pharm. Res., 16, 1576-1581, 1999.
72. Nagamoto T., Hattori Y., Takayama K., Maitani Y. - Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. - Pharm Res., 21, 671-674, 2004
73. Illum L. - Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? - J. Pharm. Sci., 96, 473-483, 2007.
74. Dyer A.M., Hinchcliffe M, Watts P, Castile J, Jabbal-Gill I, Nankervis R, Smith A, Illum L. - Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. - Pharm. Res., 19, 998-1008, 2002.